The possible effects of mesalazine on the intestinal microbiota
Authors:
Open Access
- 17 September 2012
- journal article
- letter
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 36 (8) , 813-814
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Mesalazine (5‐aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea‐predominant irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 2011
- Effect of dietary inorganic sulfur level on growth performance, fecal composition, and measures of inflammation and sulfate-reducing bacteria in the intestine of growing pigs1Journal of Animal Science, 2011
- Berberine attenuates pro-inflammatory cytokine-induced tight junction disruption in an in vitro model of intestinal epithelial cellsEuropean Journal of Pharmaceutical Sciences, 2010
- Oral administration of mesalazine protects against mucosal injury and permeation in dextran sulfate sodium-induced colitis in ratsScandinavian Journal of Gastroenterology, 2009
- Effects of mesalamine (5-aminosalicylic acid) on bacterial gene expressionInflammatory Bowel Diseases, 2009
- Low level of galacto-oligosaccharide in infant formula stimulates growth of intestinal Bifidobacteria and LactobacilliWorld Journal of Gastroenterology, 2008
- On the Action of 5-Amino-Salicylic Acid and Sulfapyridine on M. avium including Subspecies paratuberculosisPLOS ONE, 2007
- Spatial Organization and Composition of the Mucosal Flora in Patients with Inflammatory Bowel DiseaseJournal of Clinical Microbiology, 2005